vs
阿普塔集团（ATR）与美泰（MAT）财务数据对比。点击上方公司名可切换其他公司
美泰的季度营收约是阿普塔集团的1.8倍（$1.8B vs $962.7M），阿普塔集团净利率更高（7.7% vs 6.0%，领先1.7%），阿普塔集团同比增速更快（13.5% vs 7.3%），过去两年美泰的营收复合增速更高（47.7% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
美泰是美国知名玩具及娱乐企业，旗下影视制作部门美泰影业运营时间为2018年9月6日至2025年6月2日。其前身为2013年10月16日成立的美泰Playground Productions，更早可追溯至美泰娱乐、美泰工作室等集团原有娱乐业务品牌。
ATR vs MAT — 直观对比
营收规模更大
MAT
是对方的1.8倍
$962.7M
营收增速更快
ATR
高出6.2%
7.3%
净利率更高
ATR
高出1.7%
6.0%
两年增速更快
MAT
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.8B |
| 净利润 | $74.3M | $106.2M |
| 毛利率 | — | 45.9% |
| 营业利润率 | 11.0% | 8.0% |
| 净利率 | 7.7% | 6.0% |
| 营收同比 | 13.5% | 7.3% |
| 净利润同比 | -26.4% | -24.6% |
| 每股收益（稀释后） | $1.13 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRMAT
| Q4 25 | $962.7M | $1.8B | ||
| Q3 25 | $961.1M | $1.7B | ||
| Q2 25 | $966.0M | $1.0B | ||
| Q1 25 | $887.3M | $826.6M | ||
| Q4 24 | $848.1M | $1.6B | ||
| Q3 24 | $909.3M | $1.8B | ||
| Q2 24 | $910.1M | $1.1B | ||
| Q1 24 | $915.4M | $809.5M |
净利润ATRMAT
| Q4 25 | $74.3M | $106.2M | ||
| Q3 25 | $127.9M | $278.4M | ||
| Q2 25 | $111.7M | $53.4M | ||
| Q1 25 | $78.8M | $-40.3M | ||
| Q4 24 | $100.9M | $140.9M | ||
| Q3 24 | $100.0M | $372.4M | ||
| Q2 24 | $90.5M | $56.9M | ||
| Q1 24 | $83.1M | $-28.3M |
毛利率ATRMAT
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 50.0% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 49.4% | ||
| Q4 24 | — | 50.7% | ||
| Q3 24 | — | 53.1% | ||
| Q2 24 | — | 49.2% | ||
| Q1 24 | — | 48.0% |
营业利润率ATRMAT
| Q4 25 | 11.0% | 8.0% | ||
| Q3 25 | 14.2% | 21.9% | ||
| Q2 25 | 14.9% | 7.7% | ||
| Q1 25 | 12.8% | -6.4% | ||
| Q4 24 | 14.2% | 9.6% | ||
| Q3 24 | 15.2% | 26.5% | ||
| Q2 24 | 13.8% | 7.7% | ||
| Q1 24 | 12.2% | -4.4% |
净利率ATRMAT
| Q4 25 | 7.7% | 6.0% | ||
| Q3 25 | 13.3% | 16.0% | ||
| Q2 25 | 11.6% | 5.2% | ||
| Q1 25 | 8.9% | -4.9% | ||
| Q4 24 | 11.9% | 8.6% | ||
| Q3 24 | 11.0% | 20.2% | ||
| Q2 24 | 9.9% | 5.3% | ||
| Q1 24 | 9.1% | -3.5% |
每股收益（稀释后）ATRMAT
| Q4 25 | $1.13 | $0.32 | ||
| Q3 25 | $1.92 | $0.88 | ||
| Q2 25 | $1.67 | $0.16 | ||
| Q1 25 | $1.17 | $-0.12 | ||
| Q4 24 | $1.48 | $0.40 | ||
| Q3 24 | $1.48 | $1.09 | ||
| Q2 24 | $1.34 | $0.17 | ||
| Q1 24 | $1.23 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $1.2B |
| 总债务越低越好 | $1.1B | $2.3B |
| 股东权益账面价值 | $2.7B | $2.2B |
| 总资产 | $5.3B | $6.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 1.04× |
8季度趋势，按日历期对齐
现金及短期投资ATRMAT
| Q4 25 | $409.5M | $1.2B | ||
| Q3 25 | $264.8M | $691.9M | ||
| Q2 25 | $169.8M | $870.5M | ||
| Q1 25 | $136.8M | $1.2B | ||
| Q4 24 | $226.2M | $1.4B | ||
| Q3 24 | $327.9M | $723.5M | ||
| Q2 24 | $223.9M | $722.4M | ||
| Q1 24 | $201.1M | $1.1B |
总债务ATRMAT
| Q4 25 | $1.1B | $2.3B | ||
| Q3 25 | $546.0M | $2.3B | ||
| Q2 25 | $535.1M | $2.3B | ||
| Q1 25 | $561.2M | $2.3B | ||
| Q4 24 | $688.1M | $2.3B | ||
| Q3 24 | $822.7M | $2.3B | ||
| Q2 24 | $681.5M | $2.3B | ||
| Q1 24 | $680.4M | $2.3B |
股东权益ATRMAT
| Q4 25 | $2.7B | $2.2B | ||
| Q3 25 | $2.8B | $2.3B | ||
| Q2 25 | $2.7B | $2.2B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.5B | $2.3B | ||
| Q3 24 | $2.5B | $2.3B | ||
| Q2 24 | $2.4B | $2.0B | ||
| Q1 24 | $2.3B | $2.0B |
总资产ATRMAT
| Q4 25 | $5.3B | $6.6B | ||
| Q3 25 | $5.1B | $6.6B | ||
| Q2 25 | $4.9B | $6.2B | ||
| Q1 25 | $4.5B | $6.2B | ||
| Q4 24 | $4.4B | $6.5B | ||
| Q3 24 | $4.6B | $6.5B | ||
| Q2 24 | $4.5B | $5.9B | ||
| Q1 24 | $4.4B | $6.1B |
负债/权益比ATRMAT
| Q4 25 | 0.43× | 1.04× | ||
| Q3 25 | 0.20× | 1.03× | ||
| Q2 25 | 0.20× | 1.08× | ||
| Q1 25 | 0.22× | 1.10× | ||
| Q4 24 | 0.28× | 1.03× | ||
| Q3 24 | 0.32× | 1.01× | ||
| Q2 24 | 0.28× | 1.18× | ||
| Q1 24 | 0.29× | 1.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $796.6M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | — |
| 自由现金流率自由现金流/营收 | 10.1% | — |
| 资本支出强度资本支出/营收 | 9.0% | — |
| 现金转化率经营现金流/净利润 | 2.47× | 7.50× |
| 过去12个月自由现金流最近4个季度 | $299.6M | — |
8季度趋势，按日历期对齐
经营现金流ATRMAT
| Q4 25 | $183.7M | $796.6M | ||
| Q3 25 | $177.6M | $72.0M | ||
| Q2 25 | $126.0M | $-300.1M | ||
| Q1 25 | $82.7M | $24.8M | ||
| Q4 24 | $178.2M | $862.1M | ||
| Q3 24 | $229.3M | $155.8M | ||
| Q2 24 | $143.6M | $-252.9M | ||
| Q1 24 | $92.3M | $35.5M |
自由现金流ATRMAT
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | — | ||
| Q1 25 | $25.9M | — | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | — | ||
| Q2 24 | $75.4M | — | ||
| Q1 24 | $16.7M | — |
自由现金流率ATRMAT
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 1.8% | — |
资本支出强度ATRMAT
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 8.3% | — |
现金转化率ATRMAT
| Q4 25 | 2.47× | 7.50× | ||
| Q3 25 | 1.39× | 0.26× | ||
| Q2 25 | 1.13× | -5.62× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 6.12× | ||
| Q3 24 | 2.29× | 0.42× | ||
| Q2 24 | 1.59× | -4.45× | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
MAT
| North America Segment | $1.0B | 58% |
| International Segment | $745.6M | 42% |
